131 related articles for article (PubMed ID: 18712176)
21. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Hainsworth JD; Burris HA; Erland JB; Baker M; Scullin DC; Shaffer DW; Greco FA;
Cancer Invest; 2003 Apr; 21(2):193-9. PubMed ID: 12743984
[TBL] [Abstract][Full Text] [Related]
22. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
Halim A; Wahba H
Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature.
Zustovich F; Cartei G; Dal Bianco M; De Zorzi L; Ceravolo R; Zovato S; Salmaso F; Binato S; Artioli G; Cingarlini S; Pastorelli D
Ann Oncol; 2006 May; 17 Suppl 5():v133-6. PubMed ID: 16807442
[No Abstract] [Full Text] [Related]
24. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
[TBL] [Abstract][Full Text] [Related]
25. An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.
Pectasides D; Kalofonos HP; Samantas E; Nicolaides C; Papacostas P; Onyenadum A; Visvikis A; Skarlos D; Fountzilas G
Anticancer Res; 2001; 21(4B):3005-10. PubMed ID: 11712802
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb/IV) non-small-cell lung cancer patients aged 80 or older.
Chen YM; Perng RP; Chen MC; Tsai CM; Ming-Liu J; Whang-Peng J
Lung Cancer; 2003 May; 40(2):221-6. PubMed ID: 12711125
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer.
Buyukcelik A; Utkan G; Yalcin B; Demirkazik A
Lung Cancer; 2004 Dec; 46(3):377-8. PubMed ID: 15541824
[No Abstract] [Full Text] [Related]
28. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
[TBL] [Abstract][Full Text] [Related]
29. A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (Stage IIIB/IV) non-small cell lung cancer.
Chen YM; Perng RP; Yang KY; Liu TW; Tsai CM; Ming-Liu J; Whang-Peng J
Chest; 2000 Jun; 117(6):1583-9. PubMed ID: 10858387
[TBL] [Abstract][Full Text] [Related]
30. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine followed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage IIIB-IV non small cell lung carcinoma: a prospective randomized phase III trial of the Gruppo Oncologico Italia Meridionale.
Gebbia V; Galetta D; Caruso M; Verderame F; Pezzella G; Valdesi M; Borsellino N; Pandolfo G; Durini E; Rinaldi M; Loizzi M; Gebbia N; Valenza R; Tirrito ML; Varvara F; Colucci G;
Lung Cancer; 2003 Feb; 39(2):179-89. PubMed ID: 12581571
[TBL] [Abstract][Full Text] [Related]
31. Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens.
Kosmas C; Tsavaris N; Panopoulos C; Vadiaka M; Stavroyianni N; Kourelis T; Malamos N; Antonopoulos M; Kalofonos HP
Eur J Cancer; 2001 May; 37(8):972-8. PubMed ID: 11334721
[TBL] [Abstract][Full Text] [Related]
32. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Nicolaides C; Dimopoulos MA; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
Ann Oncol; 2000 Jul; 11(7):873-5. PubMed ID: 10997817
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.
Gridelli C; Perrone F; Gallo C; Cigolari S; Rossi A; Piantedosi F; Barbera S; Ferraù F; Piazza E; Rosetti F; Clerici M; Bertetto O; Robbiati SF; Frontini L; Sacco C; Castiglione F; Favaretto A; Novello S; Migliorino MR; Gasparini G; Galetta D; Iaffaioli RV; Gebbia V;
J Natl Cancer Inst; 2003 Mar; 95(5):362-72. PubMed ID: 12618501
[TBL] [Abstract][Full Text] [Related]
34. Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Greco FA; Gray JR; Thompson DS; Burris HA; Erland JB; Barton JH; Litchy S; Houston GA; Butts JA; Webb C; Scott C; Hainsworth JD
Cancer; 2002 Sep; 95(6):1279-85. PubMed ID: 12216096
[TBL] [Abstract][Full Text] [Related]
35. Salvage gemcitabine-vinorelbine chemotherapy in patients with metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.
Chen C; Wang FH; Wang ZQ; An X; Luo HY; Zhang L; Chen YC; Xu RH; Li YH
Oral Oncol; 2012 Nov; 48(11):1146-51. PubMed ID: 22748450
[TBL] [Abstract][Full Text] [Related]
36. Gemcitabine and vinorelbine combination in platinum-sensitive recurrent ovarian cancer.
Ferrero A; Logrippo V; Spanu PG; Fuso L; Perotto S; Daniele A; Zola P
Int J Gynecol Cancer; 2009 Dec; 19(9):1529-34. PubMed ID: 19955931
[TBL] [Abstract][Full Text] [Related]
37. Gemcitabine and targeted therapy in metastatic breast cancer.
Qu G; Perez EA
Semin Oncol; 2002 Jun; 29(3 Suppl 11):44-52. PubMed ID: 12138397
[TBL] [Abstract][Full Text] [Related]
38. Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.
Dongiovanni D; Fissore C; Berruti A; Buffoni L; Addeo A; Barone C; Polimeni MA; Ottaviani D; Bertetto O; Dongiovanni V
Lung Cancer; 2005 Feb; 47(2):269-75. PubMed ID: 15639726
[TBL] [Abstract][Full Text] [Related]
39. Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.
Recchia F; Lombardo M; De Filippis S; Rosselli M; Rea S
Anticancer Res; 2002; 22(2B):1321-8. PubMed ID: 12168945
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group.
León L; Cueva-Banuelos JF; Huidobro G; Fírvida JL; Amenedo M; Lázaro M; Romero C; Estévez SV; Barón FJ; Grande C; García Mata J; González A; Castellanos J; Gómez A; Caeiro M; Rodríguez MR; Casal J;
Lung Cancer; 2003 May; 40(2):215-20. PubMed ID: 12711124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]